// App-Quantinova.ai

582 : NUTM1-Rearranged Infant and Pediatric B Cell Precursor Acute Lymphoblastic Leukemia: A Good Prognostic Subtype Identified in a Collaborative International Study

Researchers

Presenter

  • Judith M. Boer

Principal Investigators

  • Femke M. Hormann

  • Zeljko Antic

  • Marketa Zaliova

  • Claire Schwab

  • Giovanni Cazzaniga

  • Chlo Arfeuille

  • Hlne Cav

  • Andishe Attarbaschi

  • Sabine Strehl

  • Gabriele Escherich

  • Toshihiko Imamura

  • Kentaro Ohki

  • Tanja A. Gruber

  • Rosemary Sutton

  • Agata Pastorczak

  • Tim Lammens

  • Frederic Lambert

  • Chi Kong Li

  • Enrique Carrillo de Santa Pau

  • Steve Hoffmann

  • Anja Mricke

  • Christine J. Harrison

  • Monique L. Den Boer

  • Paola De Lorenzo

  • Ronald W. Stam

  • Anke K. Bergmann

  • Rob Pieters

Medical Centers

  • Princess Maxima Center for Pediatric Oncology, Netherlands

  • PHARMO Institute, Utrecht, Netherlands

  • Centro Operativo di Ricerca Statistica, Fondazione Tettamanti, Monza, Italy

  • Institute of Human Genetics, Hannover Medical School, Hannover, Germany

  • Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

  • Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom

  • M Tettamanti Research Center, Pediatric Clinic, University of Milano-Bicocca, Monza, Italy

  • Department of Genetics, Robert Debré Hospital and University of Paris, Paris, France

  • Institut de Recherche Saint-Louis, Université de Paris,Paris,France

  • Department of Pediatrics, St Anna Childrens Hospital, Medical University of Vienna, Vienna, Austria

  • Children's Cancer Research Institute, CCRI St. Anna Kinderkrebsforschung, Vienna, Austria

  • Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany

  • Department of Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan

  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

  • Children's Cancer Institute Australia, University of NSW, Randwick, NSW, Australia

  • Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Lodz, Poland

  • Cancer Research Institute Ghent (CRIG), Ghent, Belgium

  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium

  • Centre Hospitalier Universitaire de Liege, Liege, Belgium

  • Department of Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong

  • Computational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, Madrid, Spain

  • Computational Biology, Leibniz Institute on Ageing-Fritz Lipmann Institute (FLI), Jena, Germany

  • Department of Pediatrics, Christian-Albrechts-University Kiel and Medical Center Schleswig-Holstein, Kiel, Germany

  • Erasmus MC-Sophia Childrens Hospital, Department of Pediatric Pulmonology and Allergology, Rotterdam, Netherlands

  • Centro Operativo di Ricerca Statistica, Fondazione Tettamanti, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy

Locations

  • Netherlands

  • Italy

  • Germany

  • Czech Republic

  • United Kingdom

  • France

  • Austria

  • Japan

  • United States

  • Australia

  • Poland

  • Belgium

  • Hong Kong

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved